Ear nerve stimulator could tame Kids' vomiting episodes
NCT ID NCT07465614
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a small device worn on the ear that stimulates the vagus nerve, which helps control nausea and vomiting. Researchers want to see if it can make cyclic vomiting episodes less frequent, shorter, and less severe in 120 children. Half the kids will get an active device, and half will get a sham (fake) device to see if the real one works better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- percutaneous electrical nerve field stimulation (PENFS) device
- What this could lead to
- If it works, this could offer a safe, non-drug option to reduce the frequency and severity of vomiting episodes in children with cyclic vomiting syndrome.
- What could go wrong
- This is an early-stage trial with only 120 participants, and the sham control means the real benefit may be small. The device requires weekly wear and may not work for all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Episodic vomiting that meet criteria for CVS based on the 2025 NASPGHAN guidelines for diagnosis of pediatric CVS * English-speaking * Lack of other explanation for vomiting * Intact external ear that is free of infection or severe dermatological conditions * Stable stable vital signs for their respective age * No currently implanted electrical device * Family able to accurately describe symptoms and number of vomiting episodes * At least 2 vomiting episodes during the 6 months prior to enrollment Exclusion Criteria: * Medically complex children or those who take a medication or suffer from another active disease that explain symptoms * Children or their parents who have significant developmental delay * Participants diagnosed with alternate conditions that explains their symptoms after undergoing medical workup per standard of care * Patients with findings of active disease such as intestinal malrotation, peptic ulcer disease, H.pylori gastritis, celiac disease, inflammatory bowel disease, allergic disorders, hydronephrosis, metabolic disorder or any other active chronic condition or medication that may cause of vomiting * Patients who are treated with a new drug affecting the central nervous system in the 4 weeks prior to enrollment * Pregnancy * Severe cardiopulmonary diseases such as chronic obstructive pulmonary disease (COPD) or coronary artery disease * Current chronic marijuana use defined as marijuana use \> 2 times per week over the last 6 months prior to study enrollment * Previously treated with a PENFS device
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cyclic vomiting syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Children's Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.